CytoDyn Statistics

Total Valuation

CytoDyn has a market cap or net worth of $140.06 million. The enterprise value is $169.15 million.

Market Cap	140.06M
Enterprise Value	169.15M

Important Dates

The last earnings date was Monday, January 9, 2023.

Earnings Date	Jan 9, 2023
Ex-Dividend Date	n/a

Share Statistics

CytoDyn has 993.37 million shares outstanding. The number of shares has increased by 18.02% in one year.

Shares Outstanding	993.37M
Shares Change (YoY)	+18.02%
Shares Change (QoQ)	+2.42%
Owned by Insiders (%)	0.80%
Owned by Institutions (%)	0.02%
Float	979.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	10.81
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.08

Current Ratio	0.08
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	4.28

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-503.31%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$4.31M
Employee Count	12
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, CytoDyn has paid $26.38 million in taxes.

Income Tax	26.38M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -49.64% in the last 52 weeks. The beta is 0.19, so CytoDyn's price volatility has been lower than the market average.

Beta (1Y)	0.19
52-Week Price Change	-49.64%
50-Day Moving Average	0.17
200-Day Moving Average	0.19
Relative Strength Index (RSI)	37.35
Average Volume (30 Days)	2,570,154

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	-35,000
Operating Income	-15.20M
Pretax Income	-51.69M
Net Income	-51.69M
EBITDA	-38.61M
EBIT	-38.64M
Earnings Per Share (EPS)	-$0.05

Full Income Statement

Balance Sheet

The company has $1.40 million in cash and $30.49 million in debt, giving a net cash position of -$29.08 million or -$0.03 per share.

Cash & Cash Equivalents	1.40M
Total Debt	30.49M
Net Cash	-29.08M
Net Cash Per Share	-$0.03
Equity / Book Value	-119.38M
Book Value Per Share	-0.12
Working Capital	-119.57M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-12.74M
Capital Expenditures	n/a
Free Cash Flow	-12.74M
FCF Per Share	-$0.01

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CytoDyn does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.02%
Shareholder Yield	-18.02%
Earnings Yield	-36.90%
FCF Yield	-9.10%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2